Par Drugs And Chemicals Limited Share Price & Stock Analysis

Par Drugs And Chemicals Limited (NSE: PAR) is a Vadodara, Gujarat-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹145 Cr, it ranks #2,919 by market cap among the 6,197 Indian listed companies on FinBizNet, and #60 of 86 in Medicinal Chemicals and Botanical Products. At ₹119.00 (as of 16 Nov 2026), the share price is 33.9% below its 52-week high of ₹180.00 and 52.5% above its 52-week low of ₹78.05. The share price is up 20.0% over one year and up 19.7% over three months.

Key Metrics

Current Price₹119.00
Market Cap₹145 Cr
NSE SymbolPAR
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Medicinal Chemicals and Botanical Products
P/E Ratio10.9
Return on Equity12.43%
Return on Assets6.75%
52-Week Range₹78.05 – ₹180.00
1-Year Price Change+20.0%
3-Month Price Change+19.7%
Beta (1Y)0.55
Dividend Yield0.00%
HeadquartersVadodara, Gujarat
Websitewww.pardrugs.com

Latest Quarterly Results — Q2 FY27

Revenue₹27 Cr
Net Profit₹3 Cr
Net Margin9.6%
EPS (Basic)₹2.14
Basisstandalone

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Par Drugs And Chemicals Limited Quarterly Revenue and Profit Trend

Par Drugs And Chemicals Limited reported revenue of ₹27 Cr in Q2 FY27, down 4.3% from ₹29 Cr in Q2 FY26 and down 12.3% from ₹31 Cr in Q1 FY27. It posted a net profit of ₹3 Cr for the quarter, against a net profit of ₹4 Cr in Q2 FY26 (down 36.3%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹20 Cr (Q4 FY26) to ₹31 Cr (Q1 FY27). The company was profitable in each of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹27 Cr₹3 Cr9.6%
Q1 FY27₹31 Cr₹5 Cr15.1%
Q4 FY26₹20 Cr₹1 Cr4.3%
Q3 FY26₹29 Cr₹5 Cr16.4%
Q2 FY26₹29 Cr₹4 Cr14.4%
Q1 FY26₹26 Cr₹3 Cr12.8%
Q4 FY25₹22 Cr₹2 Cr7.4%

Standalone figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 73.41% of Par Drugs And Chemicals Limited's shares as of Sept 2026, against 73.37% in Sept 2025 (+0.04 percentage points).

About Par Drugs And Chemicals Limited

Par Drugs and Chemicals Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India. The company provides API products, including magnesium hydroxide, magnesium oxide USP, sucralfate, almagate BP, dried aluminium hydroxide gel, light magnesium carbonate, magaldrate, magnesium trisilicate, colloidal silicon dioxide, aluminium magnesium silicate, magnesium aluminometasilicate, magnesium aluminosilicate-USP, magnesium oxide light, magnesium oxide heavy, magnesium aluminium hydrate, hydrotalcite, and synthetic aluminium silicate. It offers fine chemicals, such as precipitated silica, sodium aluminium silicate, amorphous aluminium hydroxide, Alusil, PARSIL-HT, aluminium hydroxide magnesium carbonate co-dried gel, magnesium aluminium silicate hydrated (pharma), and magnesium aluminium silicate hydrated (agro). It also exports its products. Par Drugs and Chemicals Limited was founded in 1982 and is based in Vadodara, India.

Products and Services

1. Manufacturing of API-This segment manufactures and sells active pharmaceutical ingredients.

Business Segments

1. Manufacturing of API-100%

Par Drugs And Chemicals Limited vs Peers — Medicinal Chemicals and Botanical Products

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Sun Pharmaceutical Industries Limited₹4,56,425 Cr39.514.72%₹16,199 Cr+11.2%
Laurus Labs Ltd₹1,31,242 Cr145.617.74%₹2,206 Cr+146.8%
Zydus Lifesciences Ltd₹1,19,651 Cr24.118.32%₹7,910 Cr+26.0%
Dr.Reddys Lab₹1,15,464 Cr26.911.52%₹8,698 Cr+14.5%
Cipla Limited₹1,14,712 Cr29.311.74%₹7,404 Cr-7.6%
Mankind Pharma₹1,09,870 Cr5712.45%₹4,338 Cr+16.7%
Aurobindo Pharma Ltd.₹1,05,150 Cr309.93%₹10,263 Cr+59.8%
Lupin Ltd₹92,087 Cr17.326.91%₹7,827 Cr+0.4%
Par Drugs And Chemicals Limited₹145 Cr10.912.43%₹27 Cr+20.0%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Par Drugs And Chemicals Limited?

Par Drugs And Chemicals Limited is trading at ₹119.00, with a market capitalisation of ₹145 Cr.

Which sector does Par Drugs And Chemicals Limited belong to?

Par Drugs And Chemicals Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).

What are the key financial ratios of Par Drugs And Chemicals Limited?

Par Drugs And Chemicals Limited has a P/E of 10.9 and a return on equity of 12.43%.

What is the stock symbol of Par Drugs And Chemicals Limited?

Par Drugs And Chemicals Limited is listed on the NSE under the symbol PAR.

How has Par Drugs And Chemicals Limited's share price moved over the past year?

Par Drugs And Chemicals Limited's share price is up 20.0% over one year and up 19.7% over three months. Its 52-week range is ₹78.05 to ₹180.00.

What were Par Drugs And Chemicals Limited's latest quarterly results?

In Q2 FY27, Par Drugs And Chemicals Limited reported revenue of ₹27 Cr and net profit of ₹3 Cr, with basic EPS of ₹2.14 (standalone, parsed from the company's exchange filing).

How have Par Drugs And Chemicals Limited's revenue and profit changed over the past year?

Par Drugs And Chemicals Limited reported revenue of ₹27 Cr in Q2 FY27, down 4.3% from ₹29 Cr in Q2 FY26 and down 12.3% from ₹31 Cr in Q1 FY27.

What is the promoter holding in Par Drugs And Chemicals Limited?

Promoters held 73.41% of Par Drugs And Chemicals Limited's shares as of Sept 2026, against 73.37% in Sept 2025 (+0.04 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.